Chair, OxCam Supercluster Board
After 30 years in the biopharmaceutical industry, Andy recently established his own consultancy business advising clients in the areas of strategy, policy development and engagement.
Andy is Chair of the OxCam Supercluster Board (SCB), comprised of globally recognised scientific enterprises, investors and world-leading universities alongside the local enterprise partnerships for the region. The board has been actively engaging with central government in support of the business case for East West Rail and policy to support growth across the region and the wider UK economy.
In his previous role at AstraZeneca, Andy oversaw the move and integration of the organization into the Cambridge area ahead of their move onto the Cambridge Biomedical Campus, reporting directly into the senior executive team. As part of that role, he was an active contributor to evolving Cambridge’s thinking in areas like transport, skill development, community amenity, housing and digital.
Andy remains active in the local Cambridge business community, sitting on the boards of Cambridge Ahead and Cambridge Network and is the Business Board representative on the Greater Cambridge Partnership Executive Board.
Andy has a first degree in Biochemistry from Kings College London, a PhD in Molecular Genetics from QMW College London and post-doctoral experience gained at the University of British Columbia.
